Research
Healthcare
lf0’s Healthcare hub collects every equity research note on medical device and diagnostics companies, where regulatory approval cycles, reimbursement dynamics, and innovation pipelines drive long-run returns more than quarterly noise. Coverage in this sector currently includes Abbott Laboratories (ABT), Boston Scientific (BSX), and Intuitive Surgical (ISRG). lf0 revisits these names periodically as new clinical data, product launches, and competitive dynamics reshape the investment case, so each company’s archive is organized chronologically rather than as a single static snapshot.
Lantheus Stock Analysis: Buy or Sell? Valuation, Margins & Growth
Lantheus (LNTH) is rated Hold because strong cash generation and a low-debt balance sheet are offset by uneven quarterly revenue growth. Its 24.1x trailing P/E…
Schrödinger Stock Analysis: Buy or Sell? Valuation & Cash Burn
Schrödinger (SDGR) is rated Sell because its platform quality has not yet translated into durable cash generation. The valuation still assumes stronger growth, while operating…
Nutex Health Stock Analysis: Buy or Sell? Free Cash Flow, Valuation, Reimbursement Risk
Nutex Health Inc. (NUTX) is rated Buy in this stock analysis because it is already turning revenue into strong free cash flow, with a 15.6%…
Stereotaxis Stock Analysis: Buy or Sell? Cash Burn, Revenue, Valuation & Margins
Stereotaxis (STXS) is rated Sell as uneven revenue and ongoing cash burn outweigh the platform’s gross-margin potential. A 4.6x EV/revenue multiple looks demanding while levered…
Owlet Stock Analysis: Buy or Sell? Valuation, Cash Burn, Margin
Owlet (OWLT) carries a Sell rating because valuation outruns cash generation and operating leverage. Gross margin is solid, but customer concentration and negative free cash…
Clover Health Stock Analysis: Buy or Sell? Valuation & Margins, Cash Flow
Clover Health Investments Corp. (CLOV) is rated Hold after its first profitable quarter, but trailing margins and free cash flow still lag. The business needs…
GeneDx Stock Analysis: Buy or Sell? Valuation, Cash Flow & Margins
GeneDx Holdings Corp. (WGS) is rated Sell as the market prices in a clean earnings recovery that cash flow and margin trends do not yet…
Cigna Group Stock Analysis: Buy or Sell? Valuation, Cash Flow & Margin
The Cigna Group (CI) is rated Hold as its durable cash generation offsets a post-divestiture earnings base that still needs to prove itself. The 9.0%…
Teva Pharmaceutical Stock Analysis: Buy or Sell? Valuation, Growth & Margins
Teva Pharmaceutical Industries Ltd. (TEVA) is rated Hold as the stock has already rerated on an earnings recovery, while revenue still faces generic pricing pressure.…
Incyte Stock Analysis: Valuation, Patent Cliff, Cash Flow & Growth
Incyte (INCY) is rated Hold as strong cash generation and reasonable valuation are offset by the looming 2028 JAKAFI patent cliff. The company is profitable,…
Most Popular Research